首页> 外文期刊>Composite interfaces >Comparison of the drug delivery properties of different biocompatible polymer-matrix materials with potential as intra-oral devices
【24h】

Comparison of the drug delivery properties of different biocompatible polymer-matrix materials with potential as intra-oral devices

机译:不同生物相容性聚合物基质材料作为口腔内装置的潜力的药物传递特性比较

获取原文
获取原文并翻译 | 示例
           

摘要

The application of polymers as the drug delivery systems for treating oral infections is a relatively new area of research. The present study was to test and compare the drug release properties of several biocompatible polymeric materials such as EVA copolymer, methacrylate copolymers (poly(EMA-co-HMA)) and polymer blends of poly(ethyl methacrylate) (PEMA) and poly(n-hexyl methacrylate) (PHMA). The effects of polymer composition, drug loading and solubilizing surfactants on the release of the antibacterial drug chlorhexidine diacetate (CHDA), the antifungal drug, nystatin (NYS), and the antiviral drug, acyclovir (ACY), have been studied. Measurements of the in vitro rate of drug release showed a sustained release of drug over extended periods of time. Different polymers showed different drug release rates and EVA copolymer gave the highest rate. Drug release rates increased steadily with increasing drug load and with the addition of surfactants. This study demonstrates that the three therapeutic agents exhibited a Sustained rate of drug release from polymers over extended periods of time. By varying polymer compositions as well as the drug concentration (loading), it is possible to control the drug release rates to a desired value. The drug release rate is enhanced by addition of surfactants that solubilize drugs in the polymers. Current treatment of oral infections consists of systemic administration of therapeutic agents at very high concentrations leading to significant toxicity levels and morbidity. In order to avoid serious side effects, an oral drug delivery device based on these polymeric materials has shown significant promise and potential to deliver the drugs directly to the site of infections. C
机译:聚合物作为治疗口腔感染的药物传递系统的应用是一个相对较新的研究领域。本研究旨在测试和比较几种生物相容性聚合物材料的药物释放特性,例如EVA共聚物,甲基丙烯酸酯共聚物(聚(EMA-co-HMA))以及聚甲基丙烯酸乙酯(PEMA)和聚(n)的聚合物共混物。 -甲基丙烯酸己酯)(PHMA)。研究了聚合物组成,载药量和增溶表面活性剂对抗菌药物双乙酸洗必泰(CHDA),抗真菌药物制霉菌素(NYS)和抗病毒药物阿昔洛韦(ACY)释放的影响。体外药物释放速率的测量显示了药物在延长的时间内持续释放。不同的聚合物显示不同的药物释放速率,而EVA共聚物的释放速率最高。随着载药量的增加和表面活性剂的添加,药物的释放速率稳定增加。这项研究表明,这三种治疗剂在较长时间内均表现出从聚合物中释放药物的持续速率。通过改变聚合物组成以及药物浓度(负载),可以将药物释放速率控制到所需值。通过添加可溶解聚合物中药物的表面活性剂,可以提高药物释放速率。当前口腔感染的治疗包括以非常高的浓度全身性给予治疗剂,导致明显的毒性水平和发病率。为了避免严重的副作用,基于这些聚合物材料的口服药物递送装置已显示出将药物直接递送至感染部位的巨大希望和潜力。 C

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号